Drug Trials Snapshot: KERENDIA (finerenone)

Drug Trials Snapshot: KERENDIA (finerenone) KERENDIA is a drug used in adults with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) to reduce the rate of decline in kidney function, including development of kidney failure, and to reduce the risk of having a heart attack (myocardial infarction), developing heart failure (a weak heart that cannot pump enough blood to meet the body’s needs), and dying from problems with the heart or blood vessels (cardiovascular disease). https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshot-kerendia